Strs Ohio Apellis Pharmaceuticals, Inc. Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 2,578 shares of APLS stock, worth $49,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,578

Previous 2,577 0.04%

Holding current value

$49,652

Previous $44,000 31.82%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$17.42 - $28.65 $17 - $28	1 Added 0.04%	2,578 $58,000
Q2 2025 Aug 04, 2025	BUY	$16.36 - $23.0 $42,159 - $59,271	2,577 New	2,577 $44,000
Q2 2024 Aug 05, 2024	BUY	$38.07 - $59.71 $671,935 - $1.05 Million	17,650 New	17,650 $677,000
Q2 2023 Jul 31, 2023	SELL	$76.68 - $93.31 $358,785 - $436,597	-4,679 Reduced 38.35%	7,521 $685,000
Q1 2023 Aug 02, 2023	BUY	$46.59 - $66.96 $217,994 - $313,305	4,679 Added 62.21%	12,200 $804,000
Q1 2023 Apr 27, 2023	BUY	$46.59 - $66.96 $83,862 - $120,527	1,800 Added 17.31%	12,200 $804,000
Q4 2022 Jan 26, 2023	SELL	$43.24 - $61.04 $108,100 - $152,600	-2,500 Reduced 19.38%	10,400 $537,000
Q3 2022 Oct 27, 2022	BUY	$44.76 - $69.66 $165,612 - $257,742	3,700 Added 40.22%	12,900 $881,000
Q2 2022 Jul 25, 2022	BUY	$35.07 - $59.21 $210,420 - $355,260	6,000 Added 187.5%	9,200 $416,000
Q1 2022 Apr 21, 2022	BUY	$35.46 - $54.12 $3,546 - $5,412	100 Added 3.23%	3,200 $162,000
Q4 2021 Jan 24, 2022	SELL	$30.74 - $49.16 $651,688 - $1.04 Million	-21,200 Reduced 87.24%	3,100 $146,000
Q3 2021 Oct 22, 2021	BUY	$31.4 - $69.84 $260,620 - $579,672	8,300 Added 51.88%	24,300 $800,000
Q2 2021 Jul 26, 2021	BUY	$40.9 - $64.9 $654,400 - $1.04 Million	16,000 New	16,000 $1.01 Million
Q1 2021 Apr 23, 2021	SELL	$40.8 - $57.39 $138,720 - $195,126	-3,400 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$30.79 - $57.2 $104,686 - $194,480	3,400 New	3,400 $194,000
Q3 2020 Dec 14, 2020	SELL	$25.89 - $33.65 $253,722 - $329,770	-9,800 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$24.8 - $38.49 $528,240 - $819,837	-21,300 Reduced 68.49%	9,800 $320,000
Q4 2019 Jan 24, 2020	SELL	$22.1 - $30.8 $59,670 - $83,160	-2,700 Reduced 7.99%	31,100 $952,000
Q3 2019 Oct 21, 2019	BUY	$24.09 - $32.18 $814,242 - $1.09 Million	33,800 New	33,800 $814,000
Q2 2018 Aug 06, 2018	SELL	$19.63 - $30.0 $60,853 - $93,000	-3,100 Closed	0 $0
Q4 2017 Jan 23, 2018	BUY	$12.71 - $21.7 $39,401 - $67,270	3,100	3,100 $67,000

Others Institutions Holding APLS

# of Institutions

306

Shares Held

135M

Call Options Held

2.97M

Put Options Held

623K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.12B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account